These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17118142)
1. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. Chen T; Guo L; Zhang L; Shi L; Fang H; Sun Y; Fuscoe JC; Mei N BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S20. PubMed ID: 17118142 [TBL] [Abstract][Full Text] [Related]
2. Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid. Meng F; Li Z; Yan J; Manjanatha M; Shelton S; Yarborough S; Chen T Mutagenesis; 2014 Sep; 29(5):357-65. PubMed ID: 25106556 [TBL] [Abstract][Full Text] [Related]
3. Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid. Li Z; Qin T; Wang K; Hackenberg M; Yan J; Gao Y; Yu LR; Shi L; Su Z; Chen T BMC Genomics; 2015 May; 16(1):365. PubMed ID: 25952319 [TBL] [Abstract][Full Text] [Related]
4. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Arlt VM; Zuo J; Trenz K; Roufosse CA; Lord GM; Nortier JL; Schmeiser HH; Hollstein M; Phillips DH Int J Cancer; 2011 Jan; 128(1):21-32. PubMed ID: 20232387 [TBL] [Abstract][Full Text] [Related]
5. Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats. Chen L; Mei N; Yao L; Chen T Toxicol Lett; 2006 Sep; 165(3):250-6. PubMed ID: 16764999 [TBL] [Abstract][Full Text] [Related]
6. Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys. Su Z; Li Z; Chen T; Li QZ; Fang H; Ding D; Ge W; Ning B; Hong H; Perkins RG; Tong W; Shi L Chem Res Toxicol; 2011 Sep; 24(9):1486-93. PubMed ID: 21834575 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Chen T; Li Z; Yan J; Yang X; Salminen W Mutagenesis; 2012 Jan; 27(1):59-66. PubMed ID: 21976715 [TBL] [Abstract][Full Text] [Related]
8. Oral exposure to aristolochic acid I induces gastric histological lesions with non-specific renal injury in rat. Pu XY; Shen JY; Deng ZP; Zhang ZA Exp Toxicol Pathol; 2016 Jun; 68(6):315-20. PubMed ID: 27019954 [TBL] [Abstract][Full Text] [Related]
9. Selective toxicity of aristolochic acids I and II. Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392 [TBL] [Abstract][Full Text] [Related]
10. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Tao L; Zeng Y; Wang J; Liu Z; Shen B; Ge J; Liu Y; Guo Y; Qiu J Mol Med Rep; 2015 Nov; 12(5):6533-46. PubMed ID: 26397152 [TBL] [Abstract][Full Text] [Related]
11. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy. Debelle F; Nortier J; Arlt VM; De Prez E; Vienne A; Salmon I; Phillips DH; Deschodt-Lanckman M; Vanherweghem JL Arch Toxicol; 2003 Apr; 77(4):218-26. PubMed ID: 12698237 [TBL] [Abstract][Full Text] [Related]
12. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389 [TBL] [Abstract][Full Text] [Related]
13. Comparison of DNA and RNA Adduct Formation: Significantly Higher Levels of RNA than DNA Modifications in the Internal Organs of Aristolochic Acid-Dosed Rats. Leung EM; Chan W Chem Res Toxicol; 2015 Feb; 28(2):248-55. PubMed ID: 25555167 [TBL] [Abstract][Full Text] [Related]
14. Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells. Chen YY; Chung JG; Wu HC; Bau DT; Wu KY; Kao ST; Hsiang CY; Ho TY; Chiang SY Oncol Rep; 2010 Jul; 24(1):141-53. PubMed ID: 20514455 [TBL] [Abstract][Full Text] [Related]
15. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. Chang SY; Weber EJ; Sidorenko VS; Chapron A; Yeung CK; Gao C; Mao Q; Shen D; Wang J; Rosenquist TA; Dickman KG; Neumann T; Grollman AP; Kelly EJ; Himmelfarb J; Eaton DL JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202460 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis. Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860 [TBL] [Abstract][Full Text] [Related]
17. Urinary Time- or Dose-Dependent Metabolic Biomarkers of Aristolochic Acid-Induced Nephrotoxicity in Rats. Hu X; Shen J; Pu X; Zheng N; Deng Z; Zhang Z; Li H Toxicol Sci; 2017 Mar; 156(1):123-132. PubMed ID: 28115647 [TBL] [Abstract][Full Text] [Related]
18. Aristolochic acid I metabolism in the isolated perfused rat kidney. Priestap HA; Torres MC; Rieger RA; Dickman KG; Freshwater T; Taft DR; Barbieri MA; Iden CR Chem Res Toxicol; 2012 Jan; 25(1):130-9. PubMed ID: 22118289 [TBL] [Abstract][Full Text] [Related]
19. Induction of hepatic nodules in the rat by aristolochic acid. Rossiello MR; Laconi E; Rao PM; Rajalakshmi S; Sarma DS Cancer Lett; 1993 Jul; 71(1-3):83-7. PubMed ID: 8364902 [TBL] [Abstract][Full Text] [Related]
20. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat. Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]